期刊文献+

临床药师参与1例进展性脑梗死并抑郁障碍患者的药学监护 被引量:2

Clinical Pharmacist’s Participation in Pharmaceutical Care of a Patient with Progressive Cerebral Infarction Complicate with Depression
下载PDF
导出
摘要 目的探讨临床药师在进展性脑梗死并抑郁障碍治疗过程中的作用。方法针对医院收治的1例进展性脑梗死并抑郁障碍患者,临床药师结合患者年龄、疾病、用药史、药物相互作用及药品不良反应等情况进行药学监护,包括参与治疗方案的制订,指导护士规范用药,对患者进行用药教育,促进合理用药。结果患者临床症状明显好转,病情稳定,出院后进行康复训练。结论临床药师可更好地利用自身药学专业知识积极参与临床药物治疗方案的制订,协助医师优化临床给药方案。 Objective To investigate the role of clinical pharmacists in the treatment of progressive cerebral infarction complicated with depression.Methods For a patient with progressive cerebral infarction complicated with depression in our hospital,clinical pharmacists provided pharmaceutical care based on the patient’s age,disease,medication history,drug interaction and adverse drug reactions,including participating in the formulation of the treatment plan,guiding nurses to standardize medication,conducting medication education for patients,and promoting rational drug use.Results The patient’s clinical symptoms were obviously improved,and his condition was stable,and the rehabilitation training was carried out after discharge.Conclusion Clinical pharmacists can make better use of their own pharmaceutical professional knowledge,actively participate in the formulation of clinical treatment plan,and assist physician in optimizing the clinical medication plan.
作者 孟倩颖 刘澍楠 MENG Qianying;LIU Shunan(Department of Pharmacy,Cangshan Branch of the 900 Hospital of PLA Joint Service Support Force,Fuzhou,Fujian,China 350002)
出处 《中国药业》 CAS 2021年第4期89-92,共4页 China Pharmaceuticals
关键词 进展性脑梗死 抑郁障碍 药学监护 临床药师 progressive cerebral infarction depressive disorder pharmaceutical care clinical pharmacist
  • 相关文献

参考文献6

二级参考文献101

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1823
  • 2Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 3张琼华,施光峰,李谦,陈明泉.甘草酸二铵肠溶胶囊治疗慢性肝炎2396例[J].中华传染病杂志,2007,25(3):175-176. 被引量:16
  • 4E.Pukenyte,F.X.Lescure,D.Rey,C.Rabaud,B.Hoen,P.Chavanet,A.P.Laiskonis,J.L.Schmit,T.May,Y.Mouton,Y.Yazdanpanah,马玙,张立兴.HIV感染者抗结核治疗过程中严重肝毒性反应的发生率及其危险因素[J].国际结核病与肺部疾病杂志,2007,2(1):30-35. 被引量:13
  • 5Frere C, Cuisset T, Morange PE, et al. Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronarysyndrome [J]. Am J Cardiol, 2008, 101: 1088-1093.
  • 6Fontana P, Senouf D, Mach F. Biological effect of increased maintenance dose of elopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C193 2 allele on clopi- dogrel responsiveness ⅡThromb Res, 2008,121: 463-468.
  • 7Clarke TA,Waskell LA. The Metabolism of clopidogrel is cata- lyzed by human cytochrome P450 3A and is inhibited by atorv- astatin [J]. Drug Metab Dispos,2003,31 ( 1 ) : 53-59.
  • 8Herbert J M, Frehel D, Valle E, et al. Biochemical and pharma- cological properties of clopidogrel: a new ADP receptor antago- nist[J]. Eur Heart J, 1999(suppA) :A21-A40.
  • 9Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin reduces the ability of dopidogrel to inhibit platelet aggregation: a new drug- dg interaction[J]. Circulation, 203, 107( 1 ) : 32-37.
  • 10Neubaner H, Gunesdogan B, Hanefeld C, et al. Lipophilic statin interfere with the inhibitory effects of elopidogrel on plateletfunction- a flow cytometry study [J]. Eur Heart J, 21)03, 24(19) : 1744-1749.

共引文献2828

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部